The headline numbers for Maximus (MMS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Maximus (MMS) came out with quarterly earnings of $1.62 per share, missing the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.46 per share a year ago.
Evaluate the expected performance of Maximus (MMS) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Maximus has proven its business model resilient, with stable top- and bottom-line growth, margin expansion above historical averages, and strong EPS momentum supported by share buybacks. Federal Services is the growth engine, now 57% of revenue, where higher clinical volumes, scalability, and automation are driving margins above 18%, well ahead of other segments. U.S. Services faces YoY declines after pandemic unwinding, but longer-term growth opportunities remain through OBBBA-driven Medicaid checks, SNAP accuracy programs, and potential UI outsourcing.
After reaching an important support level, Maximus, Inc. (MMS) could be a good stock pick from a technical perspective. MMS recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
MMS posts strong Q3 earnings and lifts 2025 guidance with higher revenues, profit and margin targets.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Maximus, Inc. (NYSE:MMS ) Q3 2025 Earnings Conference Call August 7, 2025 9:00 AM ET Company Participants Bruce L. Caswell - President, CEO & Director David W.
While the top- and bottom-line numbers for Maximus (MMS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Maximus (MMS) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.74 per share a year ago.
Get a deeper insight into the potential performance of Maximus (MMS) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.